Skip to Main Content

Edwards Lifesciences Corp

EW Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of EW by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Sale $1,001 - $15,000 Mar 30, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 23, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Feb 05, 2026
Josh Gottheimer House / D Sale $1,001 - $15,000 Nov 19, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Oct 07, 2025
Jefferson Shreve House / R Sale $50,001 - $100,000 May 12, 2025
Bruce Westerman House / R Sale $1,001 - $15,000 Apr 21, 2025
Robert Bresnahan House / R Purchase $1,001 - $15,000 Apr 08, 2025
Jefferson Shreve House / R Purchase $15,001 - $50,000 Apr 07, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 12, 2025
Bruce Westerman House / R Purchase $1,001 - $15,000 Mar 03, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 12, 2024
Byron Donalds House / R Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Markwayne Mullin Senate / R Sale (Partial) $15,001 - $50,000 Aug 20, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Aug 02, 2024
Mike Kelly House / R Sale $1,001 - $15,000 Apr 11, 2024
Ro Khanna House / D Purchase None N/A
Josh Gottheimer House / D Purchase $1,001 - $15,000 Dec 11, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 05, 2023
John R. Curtis House / R Sale $1,001 - $15,000 Dec 04, 2023
Ro Khanna House / D Sale $15,001 - $50,000 Nov 06, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Nov 06, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Nov 03, 2023
Byron Donalds House / R Sale $1,001 - $15,000 Oct 19, 2023
Byron Donalds House / R Sale $1,001 - $15,000 Oct 19, 2023
Markwayne Mullin Senate / R Purchase $1,001 - $15,000 Oct 03, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Oct 02, 2023
Markwayne Mullin Senate / R Purchase $15,001 - $50,000 Sep 13, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Sep 05, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Aug 29, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Jul 28, 2023
John R. Curtis House / R Purchase $1,001 - $15,000 Jun 21, 2023
Zoe Lofgren House / D Sale $1,001 - $15,000 May 25, 2023
John R. Curtis House / R Purchase $1,001 - $15,000 Apr 26, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 25, 2023
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Apr 03, 2023
Daniel S. Goldman House / D Purchase $15,001 - $50,000 Mar 06, 2023
Diana Harshbarger House / R Purchase $1,001 - $15,000 Jan 25, 2023
Diana Harshbarger House / R Purchase $1,001 - $15,000 Jan 25, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 02, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 03, 2022
Diana Harshbarger House / R Purchase $1,001 - $15,000 Oct 27, 2022
Diana Harshbarger House / R Purchase $1,001 - $15,000 Oct 27, 2022
Diana Harshbarger House / R Purchase $1,001 - $15,000 Oct 27, 2022
Diana Harshbarger House / R Purchase $1,001 - $15,000 Oct 27, 2022
Ro Khanna House / D Sale None Sep 29, 2022
Ro Khanna House / D Sale $1,001 - $15,000 Sep 29, 2022
EW Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
EW Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
EW Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in EW holdings by institutional investors

Quarterly net insider trading by EW's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $340,000 Apr 20, 2026 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $350,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid Trade (domestic/foreign)
  • $280,000 Oct 20, 2025 Issue: Taxation/Internal Revenue Code Trade (domestic/foreign) Health Issues Medicare/Medicaid
  • $360,000 Jul 18, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $350,000 Apr 18, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Veterans
  • $390,000 Jan 17, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign)
  • $350,000 Oct 18, 2024 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $370,000 Aug 26, 2024 Issue: Veterans Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $380,000 Jul 18, 2024 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Jan 22, 2024 Issue: Health Issues Medicare/Medicaid
  • $60,000 Jan 22, 2024 Issue: Health Issues Medicare/Medicaid
  • $330,000 Oct 17, 2023 Issue: Veterans Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $350,000 Jan 17, 2023 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $310,000 Oct 20, 2022 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $330,000 Jul 20, 2022 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $380,000 Apr 27, 2022 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $260,000 Apr 20, 2022 Issue: Trade (domestic/foreign) Clean Air and Water (quality) Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $340,000 Jan 20, 2022 Issue: None
  • $290,000 Oct 20, 2021 Issue: None
  • $240,000 Jul 20, 2021 Issue: None
  • $240,000 Apr 19, 2021 Issue: None
  • $310,000 Jan 20, 2021 Issue: None
  • $230,000 Oct 19, 2020 Issue: None
  • $360,000 Jul 20, 2020 Issue: None
  • $340,000 Apr 20, 2020 Issue: None
  • $340,000 Jan 21, 2020 Issue: None
  • $250,000 Oct 21, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $380,000 Jul 19, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $350,000 Jul 19, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $310,000 May 13, 2019 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $250,000 Oct 08, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $390,000 Jul 31, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $320,000 Jul 20, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $210,000 Apr 16, 2018 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $190,000 Oct 20, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $250,000 Jul 20, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $230,000 Apr 17, 2017 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $180,000 Jan 17, 2017 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $220,000 Oct 20, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $230,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $320,000 Apr 19, 2016 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $190,000 Jan 19, 2016 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $210,000 Oct 20, 2015 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $260,000 Jul 20, 2015 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $340,000 Apr 17, 2015 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $200,000 Jan 19, 2015 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $210,000 Oct 20, 2014 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Veterans
  • $230,000 Jul 18, 2014 Issue: Health Issues Taxation/Internal Revenue Code Trade (domestic/foreign) Veterans Medicare/Medicaid
  • $250,000 Apr 21, 2014 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $220,000 Jan 21, 2014 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $210,000 Oct 21, 2013 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $300,000 Jul 19, 2013 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Trade (domestic/foreign)
  • $360,000 Apr 19, 2013 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $280,000 Jan 18, 2013 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $270,000 Oct 18, 2012 Issue: Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
  • $240,000 Jul 20, 2012 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $360,000 Apr 20, 2012 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $230,000 Jan 19, 2012 Issue: Medical/Disease Research/Clinical Labs Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $250,000 Oct 20, 2011 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues Taxation/Internal Revenue Code
  • $290,000 Jul 20, 2011 Issue: Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $320,000 Apr 20, 2011 Issue: Medicare/Medicaid Copyright/Patent/Trademark Health Issues Medical/Disease Research/Clinical Labs Taxation/Internal Revenue Code Transportation
  • $240,000 Jan 20, 2011 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $210,000 Oct 20, 2010 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $250,000 Jul 19, 2010 Issue: Torts Medical/Disease Research/Clinical Labs Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
  • $290,000 Apr 19, 2010 Issue: Torts Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Trade (domestic/foreign) Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $240,000 Jan 20, 2010 Issue: Torts Medical/Disease Research/Clinical Labs Health Issues Trade (domestic/foreign) Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $240,000 Oct 19, 2009 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Torts Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $300,000 Jul 20, 2009 Issue: Taxation/Internal Revenue Code Copyright/Patent/Trademark Health Issues Trade (domestic/foreign) Medicare/Medicaid Medical/Disease Research/Clinical Labs Torts
  • $180,000 Apr 28, 2009 Issue: Medicare/Medicaid Health Issues Budget/Appropriations
  • $270,000 Apr 28, 2009 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Copyright/Patent/Trademark Trade (domestic/foreign) Agriculture Health Issues Budget/Appropriations
  • $115,817 Oct 20, 2008 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $178,357 Aug 13, 2008 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid Agriculture Copyright/Patent/Trademark Trade (domestic/foreign) Health Issues
  • $141,053 Jul 21, 2008 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $186,280 Feb 14, 2008 Issue: Trade (domestic/foreign) Agriculture Copyright/Patent/Trademark Health Issues Medicare/Medicaid Budget/Appropriations
  • $118,278 Aug 07, 2007 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Budget/Appropriations
  • $98,785 Jan 30, 2007 Issue: Medicare/Medicaid Agriculture
  • $93,556 Aug 08, 2006 Issue: Agriculture Medicare/Medicaid
  • $21,000 Feb 24, 2006 Issue: Trade (domestic/foreign) Medicare/Medicaid
  • $20,000 Nov 21, 2005 Issue: Trade (domestic/foreign) Medicare/Medicaid
  • $117,500 Aug 17, 2005 Issue: Trade (domestic/foreign) Medicare/Medicaid

EW Estimated quarterly lobbying spending

EW Revenue by Segment or Geography

By Segment
By Geography
EW Income Statement
EW Balance Sheet
EW Cash Flow
U.S. Patents

New EW patent grants

  • Patent Title: Apical puncture access and closure system Jun. 28, 2016
  • Patent Title: Retaining mechanisms for prosthetic valves Jun. 21, 2016
  • Patent Title: Rapidly deployable surgical heart valves Jun. 21, 2016
  • Patent Title: Prosthetic heart valve delivery system and method Jun. 14, 2016
  • Patent Title: Post-implant expandable surgical heart valve configurations Jun. 14, 2016
  • Patent Title: Systems, dies, and methods for processing pericardial tissue Jun. 07, 2016
  • Patent Title: Dynamic annuloplasty ring sizer May. 31, 2016
  • Patent Title: Double cross-linkage process to enhance post-implantation bioprosthetic tissue durability May. 31, 2016
  • Patent Title: Force-based heart valve sizer May. 24, 2016
  • Patent Title: Delivery systems for prosthetic heart valve May. 17, 2016
  • Patent Title: Four-leaflet stented mitral heart valve May. 17, 2016
  • Patent Title: Embolic deflection device May. 17, 2016
  • Patent Title: Flexible annuloplasty ring May. 03, 2016
  • Patent Title: Retaining mechanisms for prosthetic valves May. 03, 2016
  • Patent Title: Bioprosthetic tissue with reduced calcification Apr. 26, 2016
  • Patent Title: Method of implanting a self-expandable prosthetic heart valve Apr. 26, 2016
  • Patent Title: Retrograde cardioplegia delivery catheter and method for inducing cardioplegic arrest Apr. 19, 2016
  • Patent Title: Prosthetic heart valve configured to receive a percutaneous prosthetic heart valve implantation Apr. 19, 2016
  • Patent Title: Conformal expansion of prosthetic devices to anatomical shapes Apr. 19, 2016
  • Patent Title: Single catheter heart repair device and method for use Apr. 19, 2016
  • Patent Title: Expandable sheath for introducing an endovascular delivery device into a body Apr. 05, 2016
  • Patent Title: Expandable introducer sheath Apr. 05, 2016
  • Patent Title: Pre-assembled bioprosthetic valve and sealed conduit Apr. 05, 2016
  • Patent Title: Expandable clip for tissue repair Apr. 05, 2016
  • Patent Title: Prosthetic heart valve packaging and deployment methods Mar. 29, 2016
  • Patent Title: Mitral heart valve holder and storage system Mar. 22, 2016
  • Patent Title: System and method for treating valve insufficiency or vessel dilatation Mar. 22, 2016
  • Patent Title: Force-based heart valve sizer Mar. 08, 2016
  • Patent Title: System and method for crimping a prosthetic heart valve Mar. 08, 2016
  • Patent Title: Prosthetic heart valve system Feb. 02, 2016
  • Patent Title: Method of implanting a prosthetic aortic valve having non-laminar flow Jan. 26, 2016
  • Patent Title: Two-step heart valve implantation Jan. 26, 2016
  • Patent Title: Method for treating an aortic valve Jan. 26, 2016
  • Patent Title: Surgical stabilizer and closure system Jan. 05, 2016
  • Patent Title: Methods and devices for improving mitral valve function Dec. 01, 2015
  • Patent Title: Methods for deploying self-expanding heart valves Oct. 27, 2015
  • Patent Title: Prosthetic heart valve having improved commissure supports Oct. 27, 2015
  • Patent Title: Artificial heart valve with scalloped frame design Oct. 27, 2015
  • Patent Title: Methods of conditioning sheet bioprosthetic tissue Oct. 27, 2015
  • Patent Title: Expandable member for deploying a prosthetic device Oct. 20, 2015
  • Patent Title: Prosthetic heart valve delivery apparatus Oct. 13, 2015
  • Patent Title: Prosthetic mitral valve Oct. 13, 2015
  • Patent Title: Dynamic annuloplasty ring sizer Oct. 06, 2015
  • Patent Title: Three-dimensional annuloplasty ring Oct. 06, 2015
  • Patent Title: Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves Sep. 08, 2015
  • Patent Title: Delivery systems for prosthetic heart valve Sep. 01, 2015
  • Patent Title: Implantable prosthetic valve assembly and method for making the same Aug. 25, 2015
  • Patent Title: Methods for treating a heart Aug. 18, 2015
  • Patent Title: Methods for pre-stressing and capping bioprosthetic tissue Aug. 11, 2015
  • Patent Title: Active holder for annuloplasty ring delivery Aug. 11, 2015
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to EW from public contracts

EW News

Recent insights relating to EW

CNBC Recommendations

Recent picks made for EW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in EW

EW Analyst Ratings

EW Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
EW Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $EW stock a Buy, Sell, or Hold?

  • What is the price target for $EW stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

EW Top Shareholders
Shareholder
Shares Held
EW Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $EW stock?

  • Who owns the most shares of $EW stock?

  • What funds own $EW stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

EW Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view EW Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About EW

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

  • Address Irvine, CA
  • Market Cap 47.0 billion
  • Employees 16,000
  • Industrial Classification Orthopedic, Prosthetic & Surgical Appliances & Supplies
Edwards Lifesciences Corp Executive Compensation
Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation